Skip to content
Insights Hub
Publication

Low-prevalence outpatient validation (BMJ Open 2022)

Originally published on explorishealth.com

Low-prevalence outpatient validation (BMJ Open 2022)

A study published in BMJ Open on 26 September 2022 validated Cardio Explorer® in a low-to-intermediate-risk outpatient population.

The study was conducted at Maastricht University Medical Centre under the direction of Prof. Hans-Peter Brunner-La Rocca. It included 696 patients referred by their general practitioners to the cardiovascular outpatient clinic for assessment of coronary artery disease (CAD). Only 16.2% had CAD.

The AUC was 0.87 for the memetic pattern-based algorithm behind Cardio Explorer, compared with 0.80 for pre-test probability and 0.82 for the CAD consortium clinical model. Applying the model would have allowed 67.7% of patients to be discharged, with a CAD rate of 4.2% in that group.

This was the first validation of the model in a low-to-intermediate-risk population, where risk stratification matters most. The study was retrospective, and the authors note that the results need prospective confirmation.

(Image source: BMJ Publishing Group Limited)

Interested in how Cardio Explorer® applies to your coronary pathway? Our team is happy to walk you through the platform and the evidence behind it.